Creative Medical Technology Holdings (CELZ) Research & Development (2016 - 2026)
Creative Medical Technology Holdings (CELZ) recorded Research & Development of $459,200 in Q2 2026, down 8.4% from $501,261 a year earlier and down 15.2% from the prior quarter.
Powered by 
Analysis
Creative Medical Technology Holdings (CELZ) Research & Development (2016 - 2026) Analysis & Trends
On a TTM basis, Creative Medical Technology Holdings' Research & Development came in at $2.02 million as of Jun 30, 2026, down 12.3% year-over-year; for FY2025, it was $2.26 million, down 5.9% from FY2024.
- Annual Research & Development has a four-year compound annual growth rate of 113.3% (FY2021 to FY2025).
- Across earlier years, Research & Development came in at $2.4 million in FY2024 (+21.8%), $1.97 million in FY2023 (-68.6%), $6.27 million in FY2022 and $109,180 in FY2021.
- The Q2 2026 figure is the lowest quarterly Research & Development since Q1 2024.
- On a year-over-year basis, Research & Development rose in three of the last eight quarters, with an average decline of 1.9%.
- Peak year-over-year performance for Research & Development in the last five years was growth of 329.9% in Q3 2023, against a decline of 93.5% in Q4 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at $541,658 (Q1 2026), $550,077 (Q4 2025) and $465,154 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 993.80 Mn |
| 10 | Creative Medical Technology Holdings | 1.24 Mn | 1.26 Mn | - | 459,200.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 459,200.00 |
| Mar 31, 2026 | 541,658.00 |
| Dec 31, 2025 | 550,077.00 |
| Sep 30, 2025 | 465,154.00 |
| Jun 30, 2025 | 501,261.00 |
| Mar 31, 2025 | 743,304.00 |
| Dec 31, 2024 | 471,840.00 |
| Sep 30, 2024 | 581,796.00 |
| Jun 30, 2024 | 924,749.00 |
| Mar 31, 2024 | 422,392.00 |
| Dec 31, 2023 | 349,408.00 |
| Sep 30, 2023 | 992,722.00 |
| Jun 30, 2023 | 309,480.00 |
| Mar 31, 2023 | 319,029.00 |
| Dec 31, 2022 | 5.37 Mn |
| Sep 30, 2022 | 230,940.00 |
| Jun 30, 2022 | 659,695.00 |
| Mar 31, 2022 | 10,000.00 |
| Dec 31, 2021 | 50,000.00 |
| Sep 30, 2021 | 59,180.00 |
API Access
Creative Medical Technology Holdings Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=CELZ&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "CELZ", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=CELZ&period=max&api_key=YOUR_API_KEY");
const data = await res.json();